- A unique women’s health and wellness treatment

The Viveve treatment is a comfortable, single-session, 30-minute treatment performed by a trained healthcare professional in an outpatient setting. This treatment uses clinically-proven radiofrequency energy, stimulating the body’s natural collagen formation process. It is currently used in many countries around the world, the Viveve treatment has benefitted thousands of women and improved their health and quality of life.
For a FREE consultation, fill out the following information:
The Only Treatment with Algorithmically-controlled Cooling

Tissue tightening and strengthening, that is sustained up to 12 months and beyond, requires substantial heating at depth. Cryogen-cooled monopolar radiofrequency (CMRF) technology delivers volumetric heating at precise temperatures to stimulate robust neocollagenesis.
  • ​Reverse thermal gradient - cools and protects the surface mucosa while enabling significant heating of deep tissue
  • ​Capacitive coupling - distributes energy evenly across the treatment tip for uniform heating and cooling
  • ​Monopolar energy - penetrates 3-5 mm deep into connective tissue
  •  Reproducible delivery - parameters and algorithms are preset for controlled heating and cooling
The Only Treatment Tested in a Large-scale, Multicenter Sham-controlled Study
The importance of validated clinical evidence for the Viveve treatment cannot be overstated because often with women’s health and wellness there is a lack of serious attention to scientific rigor.
– Bruce Allan, PhD, MD Founder & Director, Allan Centre, Calgary Alberta Canada, Principal Investigator, Viveve Clinical Trials, Medical Consultant to Viveve, Inc.
“We as physicians have a duty of care to define outcomes, demand properly designed and controlled trials and insist that results are published in reputable, peer reviewed medical journals. In my opinion, anything less diminishes our obligation as physicians to our patients.”
Establishing a benchmark for energy-based device companies, Viveve undertook and successfully completed a multicenter, blinded, randomized, sham controlled study of an elective vaginal procedure to assess the effect the treatment had on women suffering from the changes their bodies undergo after vaginal childbirth.

The Viveve I study demonstrated:
There were NO serious adverse events in patients treated with the active treatment
Improvement of arousal and/or orgasm was statistically significant as self-reported by 9 out of 10 patients (Data on file and publication pending)
Further, two previous pilot clinical trials conducted by Viveve in the U.S. and Japan, showed sustained tightening at 12 months. (Data on file)
Why Women Want the Viveve Treatment
Women agree the treatment works because:
  • ​The treatment is designed for improving women’s health and overall quality of life
  • ​It is comfortable, discreet and a single-session
  • They can FEEL the difference
We'd love to answer any questions you have. Feel free to call us about the Viveve Treatment at Paragon.
Copyright 2020 - Mark A. Bishara M.D.
Powered By ClickFunnels.com